The Food and Drug Administration (FDA) is requiring class-wide label changes for opioid medications to provide additional information on the risks associated with long-term use.

The FDA will soon require prescription opioid manufacturers to include stronger language on the medications’ labels warning ...

A powerful new synthetic opioid, up to 1000 times stronger than morphine, has emerged in Adelaide’s street drug supply, and ...

The U.S. Food and Drug Administration is taking significant steps in the ongoing fight against the Opioid Crisis.

The FDA has announced new requirements for safety labeling on all opioid pain medications that place renewed emphasis on the risks associated with their long-term use. According to a July 31 news ...

The FDA is recommending that certain products containing 7-hydroxymitragynine be subject to the Controlled Substances Act.

ABC News' Dr. Darien Sutton breaks down the FDA's new labeling rules aimed at addressing long-term use and addiction risks.

A synthetic opioid 1,000 times more potent than morphine is infiltrating the street drug trade in Adelaide, Australia, ...

Members of the Oklahoma Opioid Abatement Board voted to approve grants for 15 public school districts on Thursday afternoon.

Opioid detection in workplace drug tests has gone up in the second quarter of the year, with employers urged to take a hard ...

A federal judge on July 28 ordered the opioid case against Publix closed due to both sides agreeing to a settlement.

West Virginia will receive an estimated $980 million over the next 17 years from a global settlement of a class action ...